Evaluation The Effect of Low Dose Aspirin On Endothelial Dysfunction in Preeclamptic Patients
Evaluation The Effect of Low Dose Aspirin On Endothelial Dysfunction in Preeclamptic Patients
Evaluation The Effect of Low Dose Aspirin On Endothelial Dysfunction in Preeclamptic Patients
21]
Original Article
Evaluation the effect of low‑dose aspirin on
endothelial dysfunction in preeclamptic patients
Mohammad Hashemi, Forouz Baktash1, Kiyan Heshmat‑Ghahdarijani, Elahe Zarean1, Saeide Bahrani
Department of Cardiology, School of Medicine, Medical Students’ Research Committee, 1Department of Obstetrics and Gynecology, School of
Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Background: Preeclampsia complicates up to 3% of pregnancies in developing countries. Endothelial dysfunction plays an important
role in pathogenesis of preeclampsia. In this study, we aim to evaluate the effect of low‑dose aspirin on endothelial dysfunction in
preeclamptic patients. Materials and Methods: in this triple‑blind randomized clinical trial, enrolled patients were divided randomly
into two groups. Acetylsalicylic acid (ASA) 80 mg or placebo will be taken daily by oral administration from the initiation of diagnosis
until 2 months after delivery. Every patient’s flow‑mediated dilation (FMD) were evaluated at the beginning of study and 2 months
after delivery with the same experienced operator at a same period of the time (3–5 pm) by high‑resolution B‑mode ultrasonographic.
T‑test or Mann–Whitney test was used in the comparison of means between the intervention and placebo groups. To compare FMD
in each group, before and after the intervention, paired t‑test was used. Results: Mean value of FMD in intervention (9.61 ± 5.58)
and control group (9.40 ± 4.33) have no significant differences before drug consumption (P = 0.089). FMD in intervention group
significantly increased after ASA consumption ([9.61 ± 5.58 vs. 13.65 ± 7.91] [P = 0.044]). Conclusion: Increase mean of FMD in
intervention group shows that this supplement can improve endothelial function.
How to cite this article: Hashemi M, Baktash F, Heshmat‑Ghahdarijani K, Zarean E, Bahrani S. Evaluation the effect of low‑dose aspirin on endothelial
dysfunction in preeclamptic patients. J Res Med Sci 2016;21:128.
Address for correspondence: Dr. Forouz Baktash, Department of Obstetrics‑Gynecology, School of Medicine, Isfahan University of Medical
Sciences, Isfahan, Iran. E‑mail: kimikat80@yahoo.com
Received: 01‑07‑2016; Revised: 14‑08‑2016; Accepted: 11‑09‑2016
Table 1: Demographic and baseline characters of patients dysfunction and platelet reactivation decrease endothelial
Paired t‑test Mean±SD P dilation.[9] In support of this study, Raghavan et al. also
Control group (38) Intervention group (37) reported that antiplatelet treatment can reduce vascular
Age 31.24±4.40 30.81±4.07 0.713 dysfunction.[10] Magen et al. in a study at 2005 showed that
BMI 24.61±2.76 23.46±2.53 0.528 addition of low‑dose aspirin to antihypertensive treatment
TG 115.78±18.34 110.63±16.95 0.525 and statins in hypertensive and hypercholesterolemic
LDL 98.03±13.78 92.92±17.19 0.203 patient can reduce systolic and diastolic blood pressure
HDL 48.92±7.15 50.71±7.91 0.392 through improved NO‑mediated endothelial function.[11,12]
FBS 90.62±8.65 90.95±7.27 0.304 Similar effects of low‑dose aspirin on blood pressure
Hemoglobin 12.28±0.94 12.67±0.94 0.194
and reduce risk of preeclampsia were seen in a study on
BMI = Body mass index; TG = Triglycerides; LDL = Low‑density lipoprotein;
HDL = High‑density lipoprotein; FBS = Fasting blood sugar; SD = Standard deviation pregnant women in Houston, and suggest that aspirin
administration in pregnancy are useful for high‑risk
Table 2: Flow‑mediated dilation in each group before mothers and are safe for fetus.[13]
and after consumption of drug/placebo
Before After P Endothelial dysfunction due to inflammation process
consumption FMD consumption FMD and imbalance between vasoconstrictor and vasodilator
Intervention 9.61±5.58 13.65±7.91 0.044 modulates are known pathophysiology of preeclampsia.
group
In endothelial disorders, such as preeclampsia, poor
Control group 9.40±4.33 9.23±4.74 0.201
placental perfusion leads to activation of platelets and
P 0.089 0.001
FMD = Flow‑mediated dilation
the clotting cascade, resulting in an imbalance among
prostacyclin (vasoactive modulates in blood flow and
occurs in an endothelium‑dependent FMD impairment inhibit aggregation) with thromboxane A2 (acting as a
environment. FMD is inversely correlated to platelet vasoconstrictor and promoting platelet aggregation).
reactivity in both controls and acute myocardial infarction Increased thromboxane and reduced prostacyclin levels
patients. This study showed that platelet adhesion and are associated with infarction and thrombotic vasculopathy,
aggregation in inflammation state lead to endothelial which caused preeclampsia and its adverse features
outcomes.[14,15] Schramm et al. in a study on aspirin effect significantly affected maternal blood pressure during
for the prevention of preeclamsia in lupus pregnant pregnancy and some endothelium‑dependent disease such
patient reported that low‑dose aspirin (60–80 mg/day) may as preeclampsia and its associated adverse outcomes.
prevent preeclampsia by modulating the thromboxane
A2/prostacyclin ratio to optimize placental blood flow Financial support and sponsorship
and prevent placental thrombosis. While aspirin will not This study was supported by Isfahan University of Medical
eliminate all cases of preeclampsia, it is currently the best Sciences, Isfahan, Iran (Grant No. 394649). All authors have
and safest available drug for influencing the pathogenesis read and approved the content of the paper.
and clinical presentation of preeclampsia. In this study,
aspirin treatment had a risk reduction of up to 20% for Conflicts of interest
preeclampsia development in lupus patient.[14] Furuno et al. There are no conflicts of interest.
in a survey about the effects of various doses of aspirin
on platelet activity and endothelial function indicate that AUTHORS’ CONTRIBUTION
aspirin at any daily dose over 81 mg suppressed platelet
activity, and the optimal dose of endothelial function was FB contributed in the conception of the work, conducting
162 mg/day. However, 660 mg/day of aspirin worsened the study, revising the draft, approval of the final version
endothelial function. This study explains aspirin plays an of the manuscript, and agreed for all aspects of the work.
important role in the primary and secondary prevention MH contributed in the conception of the work, drafting
of cardiovascular events and it has remained the most and revising the draft, approval of the final version of
cost‑effective clinical drug for over three decades. Higher the manuscript, and agreed for all aspects of the work.
doses of aspirin can cause bleeding complication and EZ contributed in the conception of the work, drafting
also impair endothelial function. A high dose of aspirin and revising the draft, approval of the final version of
achieves both platelet inhibition and vasodilation, whereas the manuscript, and agreed for all aspects of the work.
a low dose spares endothelial cyclooxygenase activity and KH contributed in the conception of the work, drafting
vasodilatation.[16] and revising the draft, approval of the final version of
the manuscript, and agreed for all aspects of the work.
Park et al. in a study at 2015 on high‑risk pregnant women SB contributed in the conception of the work, drafting
reported prescription of aspirin (60–150 mg/day) to this and revising the draft, approval of the final version of the
group, appears to be effective in reducing the prevalence manuscript, and agreed for all aspects of the work.
of early PE. Aspirin also can reduce the risk of preterm
delivery, IUGR, and prenatal death.[17] Roberge et al. study REFERENCES
showed similar effects and suggested that low‑dose aspirin
initiated at ≤16 weeks of gestation is associated with a 1. Schroeder BM; American College of Obstetricians and
greater reduction of perinatal death and other adverse Gynecologists. ACOG practice bulletin on diagnosing and
managing preeclampsia and eclampsia. American College of
perinatal outcomes than when initiated at >16 weeks.[18]
Obstetricians and Gynecologists. Am Fam Physician 2002;66:330‑1.
2. Roberts JM, Lain KY. Recent Insights into the pathogenesis of
Study limitations pre‑eclampsia. Placenta 2002;23:359‑72.
First and most important limitation of our study is small 3. Wen SW, Champagne J, Rennicks White R, Coyle D, Fraser W,
sample size due to difficulties to diagnosis pure preeclamptic Smith G, et al. Effect of folic acid supplementation in pregnancy
on preeclampsia: The folic acid clinical trial study. J Pregnancy
patients who met inclusion criteria. In addition, cultural
2013;2013:294312.
difficulties limited our study. The last but not least was an 4. Piri SH, Kiani A, Faghih Zadeh S. A survey on the prevalency
unequal period of drug administration by participants due and effect of demographic factor in preeclampsia and eclampsia.
to emergency indications for cesarean section which some Daneshvar J 2001;32:35‑42.
of the participants did meet. 5. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S,
et al. Prevention of preeclampsia and intrauterine growth restriction
with aspirin started in early pregnancy: A meta‑analysis. Obstet
CONCLUSION Gynecol 2010;116(2 Pt 1):402‑14.
6. Bujold E, Roberge S, Nicolaides KH. Low‑dose aspirin for
This study demonstrated an association between low‑dose prevention of adverse outcomes related to abnormal placentation.
aspirin and increase flow‑mediated vasodilation in the Prenat Diagn 2014;34:642‑8.
brachial artery in preeclamptic patient. Increase mean of 7. Ou HC, Lee WJ, Wu CM, Chen JF, Sheu WH. Aspirin prevents
resistin‑induced endothelial dysfunction by modulating AMPK,
FMD in groups who took regular daily oral 80 mg aspirin
ROS, and Akt/eNOS signaling. J Vasc Surg 2012;55:1104‑15.
starting right at the initiation of diagnosis until 2 months 8. Raghavan RP, Laight DW, Cummings MH. Aspirin in type 2
after delivery shows that this drug through biological diabetes, a randomised controlled study: Effect of different
pathway can improve endothelial function and can be doses on inflammation, oxidative stress, insulin resistance and
endothelial function. Int J Clin Pract 2014;68:271‑7. 14. Schramm AM, Clowse ME. Aspirin for prevention of preeclampsia
9. Shechter M, Shechter A, Hod H, Fefer P, Shenkman B, in lupus pregnancy. Autoimmune Dis 2014;2014:920467.
Koren‑Morag N, et al. Brachial artery endothelial function predicts 15. Saleh AA, Bottoms SF, Mammen EF. Low‑dose‑aspirin:
platelet function in control subjects and in patients with acute Treatment of the imbalance of increased thromboxane and
myocardial infarction. Platelets 2012;23:202‑10. decreased prostacyclin in preeclampsia. Am J Perinatol
10. Rao GH. Management of type‑2 diabetes with anti‑platelet therapies: 1992;9:311‑3.
Special reference to aspirin. Front Biosci (Schol Ed) 2011;3:1‑15. 16. Furuno T, Yamasaki F, Yokoyama T, Sato K, Sato T, Doi Y,
11. Magen E, Viskoper JR, Mishal J, Priluk R, London D, Yosefy C. et al. Effects of various doses of aspirin on platelet activity and
Effects of low‑dose aspirin on blood pressure and endothelial endothelial function. Heart Vessels 2011;26:267‑73.
function of treated hypertensive hypercholesterolaemic subjects. 17. Park F, Russo K, Williams P, Pelosi M, Puddephatt R, Walter M, et al.
J Hum Hypertens 2005;19:667‑73. Prediction and prevention of early‑onset pre‑eclampsia: Impact of
12. Monobe H, Yamanari H, Nakamura K, Ohe T. Effects of low‑dose aspirin after first‑trimester screening. Ultrasound Obstet Gynecol
aspirin on endothelial function in hypertensive patients. Clin 2015;46:419‑23.
Cardiol 2001;24:705‑9. 18. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention
13. Walsh SW. Low‑dose aspirin: Treatment for the imbalance of perinatal death and adverse perinatal outcome using
of increased thromboxane and decreased prostacyclin in low‑dose aspirin: A meta‑analysis. Ultrasound Obstet Gynecol
preeclampsia. Am J Perinatol 1989;6:124‑32. 2013;41:491‑9.